4.7 Article

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

A. Jayk Bernal et al.

Summary: This study found that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Jennifer Hammond et al.

Summary: In high-risk, unvaccinated adults, treatment of Covid-19 with nirmatrelvir plus ritonavir can significantly reduce the risk of hospitalization and death, with good safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

Ronen Arbel et al.

Summary: The study showed that among patients aged 65 years or older, the rates of hospitalization and death due to Covid-19 were significantly lower among those who received nirmatrelvir compared to those who did not. However, no evidence of benefit was found in younger adults.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Critical Care Medicine

Phenotypes and Subphenotypes of Patients With COVID-19 A Latent Class Modeling Analysis

Xiaofeng Wang et al.

Summary: The study identified distinct phenotypes and subphenotypes of COVID-19 patients through latent class analysis, which may guide basic, clinical, and translational research efforts. Among the 20,572 patients analyzed, different phenotypes and subphenotypes were identified, aiding in stratified analyses in clinical trials and characterizing the pathobiology of COVID-19 presentations for basic science researchers.

CHEST (2021)

Article Public, Environmental & Occupational Health

Material community deprivation and hospital utilization during the first year of life: an urban population-based cohort study

Cole Brokamp et al.

ANNALS OF EPIDEMIOLOGY (2019)